FDA Recommends rotavirus vaccines again
The U. S. Food and Drug Administration have recommended rotavirus vaccines again, which means that it can be prescribed as medication by the doctors.
Earlier when the new technology detected DNA from porcine circoviurs type 1 in GlaxoSmithKline's Rotarix vaccine as well as porcine circovirus type 2 in Merck's RotaTeq vaccine, the FDA suspended the use of these vaccines in March.
FDA clarified that none of the pig virus causes disease in humans and that it is appropriate to resume the use of Rotarix and RotaTeq vaccines. These vaccines are used to protect the infants from enteritis, a symptom in which the child feels an inflammation of the intestine that is usually accompanied by diarrhea.
However, there is no proof PCV1 or PCV2 pose a safety risk in humans, and fails to cause infection or illness in humans. Though, some strains of the pig virus may cause a wasting syndrome in young piglets, but it fails to harm human beings.
The officials said, “The benefits of the vaccines are substantial, and include prevention of death in some parts of the world and hospitalization for severe rotavirus disease in the United States. These benefits outweigh the risk, which is theoretical”.
To comment, login here
Or register to be able to comment.